The CEVT represents a central priority for the administration and faculty of LSU Health Shreveport through the engagement and intersection of critical public health needs, timely clinical and vaccine trials and delivery, timely and accurate COVID-19 testing, needed basic science and clinical research, key SARS-CoV2 and other pathogen clinical diagnosis, important education and outreach, surveillance, and the required training of future scientists, physicians and other health related work force members.
Leadership
Director of the CEVT

Andrew Yurochko, PhD
Professor of Internal Medicine, Microbiology and Immunology, Executive Director of Center of Excellence for Emerging Viral Threats, Assistant Director of Research of Center of Excellence for Arthritis, Director of CAIPP, Carroll Feist Endowed Chair of Viral Oncology, Associate Director of Research for Feist-Weiller Cancer Center
Associate Directors of the CEVT
Kevin Murnane, PhD
Associate Professor of Pharmacology, Toxicology and Neuroscience, Associate Professor of Psychiatry, Director of Basic Science Research for Louisiana Addiction Research Center

John A. Vanchiere, MD, PhD
Senior Associate Dean for Clinical Research, Professor of Pediatrics, Medical Director of Clinical Trials Office
Faculty
Faculty with the CEVT

Jason Bodily, PhD
Dean for School of Graduate Studies, Associate Professor of Microbiology and Immunology

Ana Maria Dragoi, MD, PhD
Assistant Professor in Molecular and Cellular Physiology, Research at Feist-Weiller Cancer Center

Nicholas E. Goeders, PhD
Professor and Chair of Pharmacology, Toxicology and Neuroscience; Professor of Psychiatry and Behavioral Medicine; Executive Director of Louisiana Addiction Research Center

Christopher Kevil, PhD
Professor of Pathology and Translational Pathobiology, Molecular and Cellular Physiology, and Cellular Biology and Anatomy, Director of Center for Redox Biology and Cardiovascular Disease, Malcolm Feist Endowed Chair of Cardiovascular Disease
Kevin Murnane, PhD
Associate Professor of Pharmacology, Toxicology and Neuroscience, Associate Professor of Psychiatry, Director of Basic Science Research for Louisiana Addiction Research Center

Dennis O'Callaghan, PhD
Boyd Professor Emeritus, Adjunct Professor of Center of Excellence for Arthritis and Rheumatology

A. Wayne Orr, PhD
Professor and Director of the Research Division for Pathology and Translational Pathobiology, Director of the Center for Cardiovascular Diseases and Sciences

Karen Stokes, PhD
Professor of Molecular and Cellular Physiology, Assistant Director of Scientific Excellence for the CCDS
Board of Directors
CEVT Board of Directors

Christopher Kevil, PhD
Professor of Pathology and Translational Pathobiology, Molecular and Cellular Physiology, and Cellular Biology and Anatomy, Director of Center for Redox Biology and Cardiovascular Disease, Malcolm Feist Endowed Chair of Cardiovascular Disease

A. Wayne Orr, PhD
Professor and Director of the Research Division for Pathology and Translational Pathobiology, Director of the Center for Cardiovascular Diseases and Sciences

John A. Vanchiere, MD, PhD
Senior Associate Dean for Clinical Research, Professor of Pediatrics, Medical Director of Clinical Trials Office

Matthew Woolard, PhD
Professor and Interim Chair of Microbiology and Immunology, O'Callaghan Family Endowed Professor of Microbiology

Andrew Yurochko, PhD
Professor of Internal Medicine, Microbiology and Immunology, Executive Director of Center of Excellence for Emerging Viral Threats, Assistant Director of Research of Center of Excellence for Arthritis, Director of CAIPP, Carroll Feist Endowed Chair of Viral Oncology, Associate Director of Research for Feist-Weiller Cancer Center